Jan Verhaegen

A decrease of the butyrate-producing species <i>Roseburia hominis</i> and <i>Faecalibacterium prausnitzii</i> defines dysbiosis in patients with ulcerative colitis

Kathleen Machiels, Marie Joossens, João Sabino et al. · Gut · 2013 · 1.9K citations

Life Sciences, Immunology, Microbiology +17

Galactomannan and Computed Tomography-Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility Study

Johan Maertens, Koen Theunissen, G. Verhoef et al. · Clinical Infectious Diseases · 2005 · 593 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation

Johan Maertens, Jan Verhaegen, Katrien Lagrou et al. · Blood · 2001 · 514 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Autopsy-Controlled Prospective Evaluation of Serial Screening for Circulating Galactomannan by a Sandwich Enzyme-Linked Immunosorbent Assay for Hematological Patients at Risk for Invasive Aspergillosis

Johan Maertens, Jan Verhaegen, Hilde Demuynck et al. · Journal of Clinical Microbiology · 1999 · 376 citations · Full text

Life Sciences, Hematology, Microbiology +14

Use of Circulating Galactomannan Screening for Early Diagnosis of Invasive Aspergillosis in Allogeneic Stem Cell Transplant Recipients

Johan Maertens, Johan Van Eldere, Jan Verhaegen et al. · The Journal of Infectious Diseases · 2002 · 342 citations · Full text

Veterinary Medicine, Infectious Diseases, Diagnostic Microbiology +14